ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $200 | -99.9% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $223,000 | +9.9% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $203,000 | -33.7% | 4,300 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $306,000 | -37.0% | 4,300 | -33.8% | 0.00% | 0.0% |
| Q4 2021 | $486,000 | +20.6% | 6,500 | -8.5% | 0.00% | 0.0% |
| Q3 2021 | $403,000 | +66.5% | 7,100 | +29.1% | 0.00% | +100.0% |
| Q2 2021 | $242,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |